A phase I trial of TRC102 (methoxyamine HCI) with temozolomide (TMZ) in patients with solid tumors and lymphomas.
Robert S. Meehan,Geraldine Helen O'Sullivan Coyne,Shivaani Kummar,Jerry M. Collins,Larry Anderson,Jennifer Zlott,Lamin Juwara,Naoko Takebe,Richard Piekarz,Howard Streicher,Elad Sharon,Barbara A. Conley,Larry Rubinstein,Deborah Wilsker,Angie B. Dull,Katherine V. Ferry-Galow, Roberti. Kinders,Ralph E. Parchment,James H. Doroshow,Alice P. Chen PROCEEDINGS OF THE 2018 CHI CONFERENCE ON HUMAN FACTORS IN COMPUTING SYSTEMS (CHI 2018)(2017)
AI 理解论文
溯源树
样例